Country Profile

Chile

Chile is a significant market for Indian pharmaceutical exports — $219M in FY 2025–26, with 4.0× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $8.64M. The compound annual growth rate since FY2015 stands at 13.4%.

🇨🇱 $219M · 4.0× growth since FY2015 · 13.4% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$219M
Exports FY2025–26 DGCIS
4.0×
Growth FY2015→2026
13.4%
CAGR FY2015→2026
88%
Medicines Share
5
Product Categories Supplied
Chile is a significant market for Indian pharmaceutical exports — $219M in FY 2025–26, with 4.0× growth over the past decade. Medicines accounts for 88% of shipments, with vaccines contributing $8.64M. The compound annual growth rate since FY2015 stands at 13.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $194M (88.4%) Medicine Ingredients $13.8M (6.3%) Vaccines $8.64M (3.9%) Surgical & Hospital Supplies $2.40M (1.1%) Traditional & Herbal $479K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Chile in the RBI overseas direct investment dataset (2011–2026).